Li Chang Ming, Dong Hua, Cao Xiaodong, Luong John H T, Zhang Xueji
School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.
Curr Med Chem. 2007;14(8):937-51.
Biosensors are of great interest for their ability to monitor clinically important analytes such as blood gases, electrolytes, and metabolites. A classic example is to monitor the dynamics of blood-glucose levels for treating diabetes. However, the current practice, based on a three decade old technology, requires a drop of blood on a test strip, which is in dire need of replacement. The increasing demands and interests in developing implantable glucose sensors for treating diabetes has led to notable progress in this area, and various electrochemical sensors have been developed for intravascular and subcutaneous applications. However, implantations are plagued by biofouling, tissue destruction and infection around the implanted sensors and the response signals must be interpreted in terms of blood or plasma concentrations for clinical utility, rather than tissue fluid levels. This review focuses on the potentials and pitfalls of implantable electrochemical sensors and presents our opinions about future possibilities of such implantable devices with respect to biocompatibility issues, long-term calibration, and other aging effects on the sensors.
生物传感器因其能够监测临床上重要的分析物(如血气、电解质和代谢物)而备受关注。一个典型的例子是监测血糖水平的动态变化以治疗糖尿病。然而,目前基于三十年前技术的做法需要在试纸上滴一滴血,这迫切需要更新换代。开发用于治疗糖尿病的可植入葡萄糖传感器的需求和兴趣日益增加,这导致该领域取得了显著进展,并且已经开发出了各种用于血管内和皮下应用的电化学传感器。然而,植入过程受到生物污垢、植入传感器周围的组织破坏和感染的困扰,并且为了临床应用,响应信号必须根据血液或血浆浓度来解释,而不是组织液水平。本综述重点关注可植入电化学传感器的潜力和缺陷,并就此类可植入设备在生物相容性问题、长期校准以及对传感器的其他老化影响方面的未来可能性提出我们的看法。